Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Anticoccidial Drugs Market

Anticoccidial Drugs Market Share

Report ID: GMI9889
Published Date: Jun 2024
Report Format: PDF

Download Free Sample

Anticoccidial Drugs Market Share

The market is characterized by several key players are vying for market share through strategies such as product innovation, partnerships, mergers, and acquisitions. Companies such as Zoetis Inc., Elanco, Merck & Co. Inc., Bayer AG, and Ceva are among the prominent players driving innovation and market growth through the development of novel anticoccidial drugs.

Anticoccidial Drugs Market Companies

Prominent players operating in the anticoccidial drugs industry include:

Bayer AG
Boehringer Ingelheim International GmbH
Ceva
Cronus Pharma LLC
Elanco Animal Health Incorporated
Huvepharma EOOD
Impextraco NV
Merck & Co., Inc.
Phibro Animal Health Corporation
Vetoquinol SA
Virbac SA
Zoetis Inc.

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The global anticoccidial drugs market size was valued at USD 183.1 million in 2023 and is anticipated to grow at 4.1% CAGR during 2024-2032, driven by the increasing demand for poultry products, such as meat and eggs, due to the growing demand for protein-rich diets.

The synthetic compounds segment of the anticoccidial drugs industry held 62.1% share in 2023 and will expand rapidly through 2032, due to its high efficacy and broad spectrum of activity against various coccidia species.

North America anticoccidial drugs market is projected to witness 3.9% CAGR during 2024-2032, owing to substantial livestock and poultry industry, where coccidiosis is a prevalent concern.

Elanco Animal Health Incorporated, Huvepharma EOOD, Impextraco NV, Merck & Co., Inc, Phibro Animal Health Corporation, Vetoquinol SA, Virbac SA, and Zoetis Inc. among others.